e-learning
resources
ERJ
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Elevated pulmonary vascular resistance predicts mortality in COPD patients
Katarina Zeder, Alexander Avian, Gerhard Bachmaier, Philipp Douschan, Vasile Foris, Teresa Sassmann, Natascha Troester, Luka Brcic, Michael Fuchsjaeger, Leigh Matthew Marsh, Bradley A. Maron, Horst Olschewski, Gabor Kovacs
Source:
Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
Journal Issue:
August
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Katarina Zeder, Alexander Avian, Gerhard Bachmaier, Philipp Douschan, Vasile Foris, Teresa Sassmann, Natascha Troester, Luka Brcic, Michael Fuchsjaeger, Leigh Matthew Marsh, Bradley A. Maron, Horst Olschewski, Gabor Kovacs. Elevated pulmonary vascular resistance predicts mortality in COPD patients. Eur Respir J, 58 (2) 2100944; 10.1183/13993003.00944-2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Patient with ankylosing spondylitis and pulmonary hypertension
CARDIAC DYSFUNCTION IN ACTIVE PULMONARY TUBERCULOSIS: DOUBLE TROUBLE!!
Related content which might interest you:
Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry
Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021
Year: 2021
Elevated pulmonary vascular resistance is associated with increased risk of death in IPF
Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension
Year: 2019
emPHasis-10 score predicts mortality in patients with pulmonary hypertension
Source: International Congress 2018 – Risk stratification in treatment of pulmonary arterial hypertension
Year: 2018
Pulmonary vascular disease(PC) and risk of mortality in patients with idiopathic pulmonary fibrosis(IPF)
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018
The impact of immediate postoperative pulmonary vascular resistance on survival in patients with chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary embolism
Year: 2009
Do COPD patients have a pulmonary vascular phenotype?
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
Increased risk of peripheral arterial disease in individuals with COPD
Source: International Congress 2017 – Prevalence, prognosis and comorbidities of COPD and factors associated with lung function
Year: 2017
Increased arterial remodelling in smokers and mild-moderate COPD patients are indicative of potential early onset of pulmonary hypertension.
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021
Borderline pulmonary hypertension is associated with exercise intolerance and increased risk for acute exacerbation in patients with interstitial lung disease
Source: International Congress 2018 – Pulmonary hypertension in lung diseases and the role of the right ventricle
Year: 2018
Elevation of cardiac troponin-I predicts long-term mortality in patients with acute exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2009 - Biomarkers and biology in COPD
Year: 2009
Smoking induced pulmonary vascular remodelling in patients with mild COPD
Source: Eur Respir J 2007; 30: Suppl. 51, 605s
Year: 2007
Low body mass index in hospitalised patients with chronic obstructive pulmonary disease (COPD): is related to low lung function and increased mortality
Source: Eur Respir J 2006; 28: Suppl. 50, 66s
Year: 2006
Circulating desmosine levels do not predict emphysema progression but are associated with cardiovascular risk and mortality in COPD
Source: Eur Respir J 2016; 47:1365-1373
Year: 2016
Elevated cardiac troponin I levels in acute pulmonary embolism predict increased long-term mortality
Source: Eur Respir J 2005; 26: Suppl. 49, 271s
Year: 2005
The composite physiological index strongly predicts mortality in interstitial lung disease (ILD) associated pulmonary hypertension (PH-ILD)
Source: International Congress 2017 – Imaging and lung disease PH
Year: 2017
Exercise dependence of serum NT-PROBNP levels in patients with precapillary pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation I
Year: 2009
Relationship between pulmonary hypertension (PH) and lung function in severe COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 252s
Year: 2001
Mechanisms underlying pulmonary vascular changes in COPD patients
Source: International Congress 2019 – Lung vessels in COPD: it is time to take them seriously!
Year: 2019
COPD is associated with an increased risk of peripheral artery disease and mortality
Source: ERJ Open Res, 4 (4) 00086-2018; 10.1183/23120541.00086-2018
Year: 2018
The change of lung diffusion capacity does not influence the prognosis in patients with pulmonary arterial hypertension associated with systemic sclerosis.
Source: International Congress 2019 – Endpoints and risk assessment of pulmonary arterial hypertension
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept